首页 | 本学科首页   官方微博 | 高级检索  
检索        

2型糖尿病伴血脂异常的研究进展
引用本文:孙海玲,荣海钦.2型糖尿病伴血脂异常的研究进展[J].医学综述,2009,15(23):3626-3629.
作者姓名:孙海玲  荣海钦
作者单位:山东省内分泌与代谢病研究所,济南,250062
摘    要:2型糖尿病患者常存在高脂血症,大约有50%合并血脂异常,2型糖尿病患者心血管疾病发生率和病死率也较高,高脂血症可以先于高血糖出现,但更多则是伴随糖代谢紊乱而作为糖尿病或代谢综合征的一部分。本文回顾了糖尿病伴血脂异常的可能机制及药物干预方法,多项研究均证明对糖尿病患者进行积极调脂治疗能显著减少其冠状动脉粥样硬化性心脏病的发生率和病死率。

关 键 词:2型糖尿病  血脂异常  机制  药物治疗

Type 2 Diabetes with Dyslipidemia Research
Institution:SUN Hai-ling ,RONG Hai-qin. ( Shandong Province Institute of endocrine and Metabolic Diseases, Jinan 250062, China)
Abstract:Patients with type 2 diabetes often exists Hyperlipemia,about 50% of patients complicated with dyslipidemia,the incidence and mortality of the cardiovascular disease in these patients is also high. Hyperlipidemia can appear in high blood sugar, but sugar is a metabolic disorder associated with diabetes or as part of the metabolic syndrome. This article reviewed the possible mechanisms and drug treatments of the dyslipidemia in diabetes,and found that the active interference in blood lipid disorder can significantly reduce the incidence and mortality of the coronary heart disease in diabetes mellitus.
Keywords:Type 2 diabetes mellitus  Dyslipidemia  Mechanism  Drug therapy
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号